ADARx Pharmaceuticals (ADRX) vs Novavax (NVAX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
ADARx Pharmaceuticals is the larger company by market cap ($1.84 billion vs $1.80 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADRX | NVAX |
|---|---|---|
| Share price | $17.21 | $10.94 |
| Market cap | $1.84B | $1.80B |
| 1-day change | -0.72% | -2.54% |
| YTD return | — | +66.96% |
| 1-year return | — | +21.69% |
| 5-year return | — | -93.07% |
| EPS (TTM) | $-1.16 | $-1.58 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $23.21 | $13.39 |
| 52-week low | $16.64 | $6.20 |
| Distance from 52-week high | -25.87% | -18.33% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +28.03% |
| Average volume | 1.34M | 5.16M |
| Shares outstanding | 106.80M | 164.95M |
| Employees | 100 | 749 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ADARx Pharmaceuticals
ADRX stock →ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
About Novavax
NVAX stock →Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 749 employees
ADRX vs NVAX FAQ
Which is bigger, ADARx Pharmaceuticals or Novavax?
ADARx Pharmaceuticals (ADRX) is larger, with a market capitalization of $1.84B compared with $1.80B for Novavax (NVAX).
Are ADARx Pharmaceuticals and Novavax in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for ADARx Pharmaceuticals and Biotechnology: Biological Products (No Diagnostic Substances) for Novavax.